SCHEMBL22775559

SCHEMBL22775559

CCS(=O)(=O)c1nn2c(-c3cc(Cl)cc(Cl)c3)ccnc2c1-c1nc2cc(C(F)(F)F)ccc2n1C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AGPAT2 O15120 1/20 0.36
▸ PTGS2 P35354 2/20 0.35
▸ RORC P51449 1/20 0.34
▸ CNR2 P34972 3/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ GRM2 Q14416 1/20 0.34
▸ NPC1 O15118 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ DDR1 Q08345 2/20 0.32
▸ PDE2A O00408 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ KIT P10721 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22776106 0.88 POLB (0.38) PTGS2NPC1NPSR1NTRK1PIM1
SCHEMBL29525576 0.88 PTGS2 (0.36) PTGS2CNR1NPC1NPSR1NTRK1
SCHEMBL29525664 0.84 AGPAT2 (0.36) AGPAT2CNR2CNR1GRM2NPC1
SCHEMBL29525944 0.84 POLB (0.36) PTGS2NPC1NPSR1NTRK1PIM1
SCHEMBL29525786 0.83 PTGS2 (0.33) PTGS2NPC1NPSR1NTRK1PIM1
SCHEMBL29525341 0.83 NPSR1 (0.41) NPC1NPSR1NTRK1PIM1KDM4E
SCHEMBL22776006 0.82 POLB (0.36) PTGS2NPC1NPSR1KDM4E
SCHEMBL22776032 0.82 NPSR1 (0.39) PTGS2CNR1NPC1NPSR1NTRK1
SCHEMBL29525864 0.82 NPSR1 (0.39) PTGS2CNR1NPC1NPSR1NTRK1
SCHEMBL29525360 0.81 POLB (0.39) NPC1NPSR1KDM4EKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983411-B1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD (IN) 2026-05-27 — — EP claimed
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents PI INDUSTRIES LTD (IN) 2025-08-12 — — US claimed
US-20220251094-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2022-08-11 — — US claimed
EP-3983411-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI Industries Ltd. (IN) 2022-04-20 — — EP claimed
WO-2020250183-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2020-12-17 — — WO claimed
EP-3983411-B1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD (IN) 2026-05-27 — — EP disclosed
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents PI INDUSTRIES LTD (IN) 2025-08-12 — — US disclosed
US-20220251094-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2022-08-11 — — US disclosed
EP-3983411-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI Industries Ltd. (IN) 2022-04-20 — — EP disclosed
WO-2020250183-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS PI INDUSTRIES LTD. (IN) 2020-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384787-B2 Fused heterocyclic compounds and their use as pest control agents DDT, ACHE, KEAP1 AGPAT2 2561/4885PTGS2 1077/4885RORC 3242/4885
US-20220251094-A1 FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS DDT, ACHE, KEAP1 AGPAT2 2561/4885PTGS2 1077/4885RORC 3242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback